Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD19 (clone 1G07J6Z). We employs the pUC (CMV-mKate-IL-17-EcoRI) vector components and the SynExpress system of the miRNA Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD19
Clone
1G07J6Z
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
CMV
Effector Gene
IL-17
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
miRNA
Carrier Type
pUC
Transformation Accuracy
0.96
Cell Culture
Plate Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.